Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates

NCT03403530 is registered in ClinicalTrials.gov with Sir Takhtasinhji General Hospital as lead sponsor.

NCT NCT03403530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03403530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study to Analyze the Efficacy of IgM Rich Immunoglobulin as an Adjunct to Antibiotics in the Treatment of Bacterial Sepsis in Very Low Birth Weight Preterm Neonates
Lead sponsor
Sir Takhtasinhji General Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 30, 2018
Completion date
September 30, 2018
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal sepsis, very low birth weight baby